NTRR Orders Initial Manufacturing Run of New pH Balance Formulas

TAMPA, Fla.--()--Neutra Corp. (OTCBB: NTRR), an emerging nutraceuticals provider, took a major step toward delivering its innovative new pH balance supplement to market by ordering an initial manufacturing run of two new formulas for testing.

Both formulas include pure, natural ingredients chosen for their special properties promoting a healthy immune system. The new all-natural supplement is being designed to alter the body’s pH balance and oxygen content to a slightly alkaline, disease-resistant state.

Once the initial manufacturing run has been received, both new formulas will be subjected to clinical trials to determine their efficacy. The formula that achieves the best results during trials will be infused with NTRR’s signature Bio-Energy for an additional round of testing.

“We’re very excited about the potential of our new formulas to dramatically support the body’s immune system , and I’m pleased to say that our development schedule for this product is proceeding as planned,” said NTRR CEO Cindy Morrissey.

Neutra Corp. is developing new products to compete in the rising nutraceuticals industry alongside Herbalife Ltd. (NYSE: HLF), Watson Pharmaceuticals, Inc. (NYSE: WPI), Plandai Biotechnology, Inc. (OTCOB: PLPL), LTS Nutraceuticals, Inc. (LTSN.PK), and Vitamin Shoppe, Inc. (NYSE: VSI).

For more information on NTRR’s nutraceuticals initiative, please visit www.neutracorp.com/investors.html.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts

Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO
info@neutracorp.com

Release Summary

NTRR Orders Initial Manufacturing Run of New pH Balance Formulas

Contacts

Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO
info@neutracorp.com